A combination of lisocabtagene maraleucel (liso-cel, Breyanzi) plus ibrutinib (Imbruvica) demonstrated a trend for better ...

Stock futures were rising Monday, paring losses after Friday’s weaker-than-expected jobs report seemed to boost the odds of ...